In this study, we prepared postbiotics from IL6 targeting L. lactis displaying ZIL6 affibody on their surface with the long term aim to evaluate their therapeutic potential in inflammatory intestinal diseases and colorectal cancer. Here, IL6 is linked to colorectal cancer.